Free Trial

Precision Optics (POCI) Competitors

Precision Optics logo
$4.74 +0.02 (+0.32%)
As of 03:26 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

POCI vs. TLSI, LAKE, AVR, PDEX, MBOT, LUCD, ICAD, NSPR, OBIO, and ZJYL

Should you be buying Precision Optics stock or one of its competitors? The main competitors of Precision Optics include TriSalus Life Sciences (TLSI), Lakeland Industries (LAKE), Anteris Technologies Global (AVR), Pro-Dex (PDEX), Microbot Medical (MBOT), Lucid Diagnostics (LUCD), icad (ICAD), InspireMD (NSPR), Orchestra BioMed (OBIO), and Jin Medical International (ZJYL). These companies are all part of the "medical equipment" industry.

Precision Optics vs. Its Competitors

TriSalus Life Sciences (NASDAQ:TLSI) and Precision Optics (NASDAQ:POCI) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings, risk and media sentiment.

TriSalus Life Sciences has a beta of 0.48, suggesting that its stock price is 52% less volatile than the S&P 500. Comparatively, Precision Optics has a beta of 0.3, suggesting that its stock price is 70% less volatile than the S&P 500.

TriSalus Life Sciences currently has a consensus price target of $10.75, suggesting a potential upside of 135.95%. Given TriSalus Life Sciences' stronger consensus rating and higher probable upside, research analysts plainly believe TriSalus Life Sciences is more favorable than Precision Optics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TriSalus Life Sciences
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
3.25
Precision Optics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

2.6% of TriSalus Life Sciences shares are owned by institutional investors. Comparatively, 13.7% of Precision Optics shares are owned by institutional investors. 27.5% of TriSalus Life Sciences shares are owned by insiders. Comparatively, 13.0% of Precision Optics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, TriSalus Life Sciences had 10 more articles in the media than Precision Optics. MarketBeat recorded 11 mentions for TriSalus Life Sciences and 1 mentions for Precision Optics. Precision Optics' average media sentiment score of 1.88 beat TriSalus Life Sciences' score of 0.29 indicating that Precision Optics is being referred to more favorably in the news media.

Company Overall Sentiment
TriSalus Life Sciences Neutral
Precision Optics Very Positive

Precision Optics has lower revenue, but higher earnings than TriSalus Life Sciences. Precision Optics is trading at a lower price-to-earnings ratio than TriSalus Life Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TriSalus Life Sciences$29.43M5.86-$30.05M-$1.18-3.86
Precision Optics$19.10M1.91-$2.95M-$0.89-5.33

Precision Optics has a net margin of -32.84% compared to TriSalus Life Sciences' net margin of -86.61%. TriSalus Life Sciences' return on equity of 0.00% beat Precision Optics' return on equity.

Company Net Margins Return on Equity Return on Assets
TriSalus Life Sciences-86.61% N/A -116.50%
Precision Optics -32.84%-54.03%-32.48%

Summary

TriSalus Life Sciences beats Precision Optics on 11 of the 17 factors compared between the two stocks.

Get Precision Optics News Delivered to You Automatically

Sign up to receive the latest news and ratings for POCI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding POCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

POCI vs. The Competition

MetricPrecision OpticsMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$36.39M$6.94B$5.69B$9.81B
Dividend YieldN/A1.30%4.61%4.07%
P/E Ratio-5.3325.5130.6725.54
Price / Sales1.9172.91463.88116.75
Price / CashN/A21.9738.2159.48
Price / Book2.865.418.986.13
Net Income-$2.95M$176.29M$3.25B$264.89M
7 Day Performance0.32%14.49%4.75%2.74%
1 Month Performance-5.59%11.08%6.74%3.14%
1 Year Performance-9.62%9.78%30.55%25.31%

Precision Optics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
POCI
Precision Optics
0.7525 of 5 stars
$4.75
+0.3%
N/A-11.6%$36.39M$19.10M-5.3380
TLSI
TriSalus Life Sciences
3.0674 of 5 stars
$3.65
+2.2%
$10.75
+194.5%
-33.7%$138.12M$29.43M-3.26106News Coverage
Earnings Report
Analyst Revision
LAKE
Lakeland Industries
4.7931 of 5 stars
$14.12
+2.6%
$26.00
+84.1%
-34.8%$134.28M$167.21M-4.692,100Positive News
AVR
Anteris Technologies Global
N/A$3.71
+6.0%
$16.50
+344.7%
N/A$133.78M$2.70M0.00138News Coverage
Earnings Report
PDEX
Pro-Dex
3.1263 of 5 stars
$39.42
+2.6%
$56.00
+42.1%
+118.1%$128.51M$53.84M14.08140Positive News
High Trading Volume
MBOT
Microbot Medical
1.6456 of 5 stars
$3.12
+8.0%
$9.00
+188.5%
+216.2%$113.51MN/A-4.8020News Coverage
Earnings Report
LUCD
Lucid Diagnostics
1.9561 of 5 stars
$1.00
0.0%
$3.55
+255.9%
+19.0%$107.92M$4.35M-0.7470News Coverage
Analyst Forecast
ICAD
icad
N/A$3.87
flat
N/AN/A$106.31M$19.61M-20.37140
NSPR
InspireMD
3.5856 of 5 stars
$2.52
-2.3%
$4.50
+78.6%
-13.8%$105.14M$7.07M-3.3650
OBIO
Orchestra BioMed
3.4062 of 5 stars
$2.72
+7.9%
$14.00
+414.7%
-52.0%$105.10M$2.64M-1.534News Coverage
Earnings Report
Analyst Forecast
ZJYL
Jin Medical International
N/A$0.64
-2.0%
N/A-81.7%$99.64M$23.50M0.00245News Coverage
Positive News
Short Interest ↓

Related Companies and Tools


This page (NASDAQ:POCI) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners